Ditazole: Difference between revisions
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 24: | Line 24: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Ditazole''' is a [[platelet]] aggregation [[inhibitor]].It is marketed in Spain and Portugal under the trade name ''Ageroplas''.<ref>''Martindale's Complete Drug Reference'',http://www.medicinescomplete.com/mc/martindale/current/2639-d.htm</ref> | '''Ditazole''' is a [[platelet]] aggregation [[inhibitor]].It is marketed in Spain and Portugal under the trade name ''Ageroplas''.<ref>''Martindale's Complete Drug Reference'',http://www.medicinescomplete.com/mc/martindale/current/2639-d.htm</ref> | ||
== References == | ==References== | ||
{{reflist|2}} | |||
{{reflist | |||
{{Antithrombotics}} | {{Antithrombotics}} | ||
[[Category: | [[Category:Drug]] | ||
[[Category:Drugs]] | [[Category:Cardiovascular Drugs]] | ||
[[Category:Antiplatelet drugs]] | |||
Latest revision as of 00:57, 26 July 2014
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C19H20N2O3 |
| Molar mass | 324.374 g/mol |
|
WikiDoc Resources for Ditazole |
|
Articles |
|---|
|
Most recent articles on Ditazole |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Ditazole at Clinical Trials.gov Clinical Trials on Ditazole at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Ditazole
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Ditazole Risk calculators and risk factors for Ditazole
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Ditazole |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ditazole is a platelet aggregation inhibitor.It is marketed in Spain and Portugal under the trade name Ageroplas.[1]
References
- ↑ Martindale's Complete Drug Reference,http://www.medicinescomplete.com/mc/martindale/current/2639-d.htm
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Antiplatelet drugs